Find uplifting stories about heroes, innovations, and solutions
5998 results for "epilepsy treatment"
Children with a devastating form of epilepsy may soon have new hope thanks to promising trial results from an experimental treatment. Praxis Precision Medicines announced their drug elsunersen successfully reduced seizures in early testing for SCN2A-related epilepsy.
Scientists in Jerusalem discovered a tiny peptide that not only reduces seizures but protects brain cells from long-term damage in treatment-resistant epilepsy. For the 40% of epilepsy patients who don't respond well to current medications, this breakthrough offers new hope.
A breakthrough treatment for seizure disorders exceeded expectations in its final clinical trial, bringing hope to millions who live with epilepsy. The drug reduced seizure frequency significantly and could reach patients by late 2026.
A breakthrough medication helped highly treatment-resistant epilepsy patients reduce their seizures by more than half in a major clinical trial. The once-daily pill works through an entirely new mechanism and could reach patients by next year.
A breakthrough treatment is transforming lives for children with Dravet syndrome, a severe form of epilepsy that can cause hundreds of seizures daily. Eight-year-old Freddie Truelove went from constant fits to just two seizures a week and is now skiing and climbing mountains.
An eight-month-old infant in Israel became the first person to receive groundbreaking gene therapy that restores missing brain function, potentially saving children from a devastating form of epilepsy. The treatment represents years of research turning into real hope for families facing ultra-rare genetic diseases.
A new biotech company just launched with $106 million to bring promising brain disorder treatments to Americans. Tortugas Neuroscience is testing four drugs for conditions that affect millions, including schizophrenia, tinnitus, and epilepsy.
A groundbreaking drug called zorevunersen slashed seizures by up to 91% in children with Dravet syndrome, a devastating form of epilepsy that causes developmental delays and sudden death. Unlike other treatments, this drug tackles the genetic root cause and could change the course of the disease.
University of Virginia researchers used gene editing to fix the DNA mutation causing a deadly form of epilepsy, potentially opening the door to cures for inherited brain disorders. The technique eliminated seizures in lab mice and improved their movement and cognitive function.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
Four promising new treatments could reach patients this spring, offering fresh hope for people battling hard-to-treat conditions. From the first-ever medication for a chronic liver infection to an at-home Alzheimer's treatment, these therapies represent real progress for patients who've been waiting.
A Shanghai neurologist discovered a potential Alzheimer's therapy after his 90-year-old mother improved cognitively following ultrasound treatment for a different condition. His trial now tests high-intensity focused ultrasound as a standalone treatment, a promising departure from mainstream research.
UK scientists created a simple blood test that tells doctors whether breast cancer treatment will work before therapy even begins. The breakthrough could spare patients from months of ineffective drugs and help them find treatments that actually work.
Patients with chronic lymphocytic leukemia now have a new treatment option that doesn't require chemotherapy and allows time off from treatment. The FDA approved the first all-oral, fixed-duration therapy for this common adult leukemia.
BestCare Treatment Services broke ground on Oregon's only residential treatment center designed specifically for Latino men struggling with substance use disorder. The culturally tailored facility will provide care entirely in Spanish, addressing critical language and cultural barriers that often prevent people from seeking help.
The FDA is accelerating reviews of three psychedelic medications for depression and PTSD, moving promising mental health treatments closer to patients who desperately need them. Millions struggling with treatment-resistant conditions could soon have groundbreaking new options.
Men with spreading prostate cancer can now postpone harsh hormone therapy for over two years thanks to a targeted radiation treatment that leaves healthy tissue untouched. A quarter of patients showed no tumors after treatment.
A new high dose version of an SMA treatment just won FDA approval, offering faster results for babies and children fighting this devastating muscle disease. The breakthrough gives families a more powerful option against a condition that once had no treatment at all.
A newly approved combination therapy is giving people with hard-to-treat multiple myeloma real hope, with over 80% of patients still alive three years after treatment. The FDA greenlit the two-injection approach after seeing results that far outpaced standard treatments.
Showing 20 of 5998